Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Ratios

enVVeno Medical (NVNO) Other financing activities (2019 - 2020)

enVVeno Medical has reported Other financing activities over the past 2 years, most recently at $360026.0 for Q2 2020.

For Q2 2020, Other financing activities fell 34.43% year-over-year to $360026.0; the TTM value through Jun 2020 reached $360026.0, down 34.43%, while the annual FY2023 figure was $5.2 million, 42.23% down from the prior year.
Other financing activities for Q2 2020 was $360026.0 at enVVeno Medical, up from $79658.0 in the prior quarter.
Over five years, Other financing activities peaked at $549060.0 in Q2 2019 and troughed at $79658.0 in Q1 2020.